Antiphospholipid antibodies and hypertension

Lupus

Volumn 13, Issue 10, 2004, Pages 769-772

  Rollino, Cristiana ^a,c   Boero, R ^a   Elia, F ^a   Montaruli, B ^b   Massara, C ^a   Beltrame, G ^a   Ferro, M ^a   Quattrocchio, G ^a   Quarello, F ^a  

^a S GIOVANNI BOSCO HOSPITAL   (Italy)

^b Ospedale Evangelico Valdese   (Italy)

^c Divisione di Nefrologia e Dialisi   (Italy)

Author keywords

Antiphospholipid antibody; Hypertension; Nephropathy; Renal failure; Thrombotic microangiopathy

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; HYPERTENSIVE AGENT; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PROTHROMBIN ANTIBODY;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE SEVERITY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; KIDNEY ARTERY STENOSIS; KIDNEY DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; THROMBOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA;

AGED; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; CASE-CONTROL STUDIES; FEMALE; GLYCOPROTEINS; HUMANS; HYPERTENSION; LUPUS COAGULATION INHIBITOR; MALE; MIDDLE AGED; RENAL ARTERY OBSTRUCTION;

EID: 7644239561     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203304lu1082oa     Document Type: Article

References (13)

1. Brandt JT, Triplett TA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 1995; 74: 1185-1190.
2. Nzerue CM, Hewan-Lowe K, Pierangeli S, Harris N. 'Black swan in the kidney': renal involvement in the anti-phospholipid antibody syndrome. Kidney Int 2002; 62: 733-744.
3. Nochy D, Daugas E, Droz D et al. The intrarenal vascular lesions associated with primary anti-phospholipid syndrome. J Am Soc Nephrol 1999; 10: 507-518.
4. Daugas E, Nochy D, Huong du LT et al. Anti-phospholipid nephropathy in systemic lupus erythematosus. J Am Soc Nephrol 2002; 13: 42-52.
5. Asherson RA, Kant KS. Antiphospholipid antibodies and the kidney. J Rheum 1993; 20: 1268-1272.
6. Godfrey T, Khamashta MA, Hughes GR. Antiphospholipid syndrome and renal artery stenosis. QJM 2000; 93: 127-129.
7. Mandreoli M, Zuccalá A, Zucchelli P. Fibromuscular dysplasia of the renal arteries associated with anti-phospholipid antibodies: two case reports. Am J Kidney Disease 1992; 20: 500-503.
8. Frostegard J. Autoimmunity, oxidized LDL and cardiovascular disease. Autoimmun Rev 2002; 1: 233-237.
9. Exner T, Triplett DA, Taberner D, Machin SJ. Guidelines for testing and revised criteria for lupus anticoagulants. SSC Subcommittee for Standardization of Lupus Anticoagulants. Thromb Haemost 1991; 65: 320-235.
10. Frostegard J, Wu R, Gillis-Haegerstrand C, Lemne C, de Faire U. Antibodies to endothelial cells in borderline hypertension. Circulation 1998; 98: 1092-1098.
11. Dropinski J, Szczeklik W, Rubis P, Sydor WJ. Anti-phospholipid antibodies and carotid artery intima media thickness in young survivors of myocardial infarction. Med Sci Monit 2003; 9: 105-109.
12. Petri M. Epidemiology of the anti-phospholipid antibody syndrome. J Autoimmun 2000; 15: 145-151.
13. Sangle SR, D'Cruz DP, Jan W et al. Renal artery stenosis in the antiphospholipid (Hughes) syndrome ad hypertension. Ann Rheum Dis 2003; 62: 999-1002.